Skip to content

Clinical Evaluation of Bioactive Resin Sealants vs Conventional Sealants in Permanent Molars

Clinical Evaluation of Bioactive Resin Based Pits & Fissures Sealants Versus Conventional Resin Based Pits & Fissures Sealants in Caries Susceptible Fissures in Permanent Molars: A Randomized Controlled Trial

Status
UNKNOWN
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03779893
Enrollment
38
Registered
2018-12-19
Start date
2019-01-31
Completion date
2020-03-31
Last updated
2019-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caries, Dental

Brief summary

This study will be conducted to evaluate the performance; in terms of retention and caries inhibition; of the newly introduced bioactive resin based pits and fissure sealant versus conventional resin based pits and fissure sealant in caries susceptible fissures in posterior molars in patients at risk of caries. Evaluation will be done by visual tactile examination & VistaCAM.

Detailed description

In the investigator's study the comparator material will be BioCoat® by Premier® ; new bioactive resin pits and fissures sealant featuring SmartCap™ Technology. SmartCap™ Technology utilizes patented semi-permeable resin microcapsules. In BioCoat, the rechargeable SmartCap microcapsules are filled with ionic solutions of fluoride, calcium and phosphate, which diffuse in and out of the sealant. Greater fluoride uptake in the presence of calcium and phosphate ions is assumed. With limited evidence based information in literature about using bioactive fissure sealants in susceptible fissures , it was found beneficial to evaluate the newly introduced material using a randomized controlled trial to test the null hypothesis that bioactive resin pits and fissure sealant will have the same clinical performance as conventional resin based pits and fissure sealant in susceptible fissures.

Interventions

COMBINATION_PRODUCTBioCoat® by Premier®.

Bioactive pits and fissure sealant

COMBINATION_PRODUCT3M™ Clinpro™ Sealant.

conventional pits and fissure sealant

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

of participants: * Patients with bilateral caries susceptible fissures in molars showing no signs of caries. * 19 - 40 years. * Males or Females. * Co-operative patients approving to participate in the trial.

Exclusion criteria

of participants: * Patients younger than 19 years old or older than 40 years old. * Pregnancy. * Disabilities. * Systemic disease or severe medical complications. * Allergic history concerning methacrylate. * Rampant caries. * Heavy smoking. * Xerostomia. * Lack of compliance. * Evidence of severe bruxism, clenching, or tempromandibular joint disorders.

Design outcomes

Primary

MeasureTime frameDescription
Retention of sealantone yearrate of sealant loss

Secondary

MeasureTime frameDescription
Caries incidenceone yearrate of caries initiation

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026